Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and Ablation System with ...

Many would have returned with atrial fib anyway, researchers say of their small, largely successful test of pulmonary-vein isolation in patients without AF already getting ablation for atrial flutter.

Cardiac ablation is very effective for people with typical atrial flutter, providing a cure for 90 percent of these patients. With atypical atrial flutter, cardiac ablation is successful for 60 to 70 ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter.

Atrial flutter and atrial fibrillation are types of abnormal heart rhythms. Learn about the similarities and differences between these two conditions.

Medtronic announced the FDA approval of its mapping and dual-energy catheter ablation system for the treatment of persistent atrial fibrillation and radiofrequency ablation of cavotricuspid ...

NATICK, Mass., Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi™ XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia ...

A nuclear stress test showed no myocardial scar or ischemia. Another DC cardioversion and radiofrequency ablation of the right-atrial isthmus successfully treated atrial flutter.

Our goal was to evaluate the efficacy and safety of cryoballoon ablation as compared with drug therapy as an initial treatment strategy in patients with symptomatic paroxysmal atrial fibrillation.

Left atrial appendage closure is a mechanical alternative to anticoagulation, but data regarding its use after atrial fibrillation ablation are lacking.

With the approval of Affera, we are excited to bring a novel mapping and ablation solution to clinicians that is intended to make atrial fibrillation treatment safer, more effective, and more ...